Peak postoperative troponin levels outperform preoperative cardiac risk indices as predictors of long-term mortality after vascular surgery. Troponins and postoperative outcomes

Journal of Critical Care

Volumn 27, Issue 1, 2012, Pages 66-72

  Marston, Nicholas ^a   Brenes, Jorge ^b   Garcia, Santiago ^a,c   Kuskowski, Michael ^a,c   Adabag, Selcuk ^a,c   Santilli, Steven ^c,d   McFalls, Edward O ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Biomarkers; Cardiac risks; Outcomes; Statins; Tissue loss; Troponins; Vascular surgery

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN;

AGED; ARTICLE; CONTROLLED STUDY; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MORTALITY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PROGNOSIS; REFERENCE VALUE; REVISED CARDIAC RISK INDEX; RISK FACTOR; SCORING SYSTEM; SURGICAL MORTALITY; SURGICAL RISK; VASCULAR SURGERY;

AGED; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; TROPONIN; VASCULAR SURGICAL PROCEDURES;

EID: 84856472589     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.06.004     Document Type: Article

References (23)

1. Fleisher L., Beckman J., Brown K., Calkins H., Chaikof E., Fleischmann K., et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007, 116:1971-1996.
2. Jaffe A. A small step for man, a leap forward for postoperative management. J Am Coll Cardiol 2003, 42:1555-1558.
3. McFalls E., Ward H., Moritz T., Apple F., Goldman S., Pierpont G., et al. Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the Coronary Artery Revascularization Prophylaxis (CARP) Trial. Eur Heart J 2008, 29:394-401.
4. Kim L., Martainez E., Faraday N., Dorman T., Fleisher L., Perler B., et al. Cardiac troponin I predicts short-term mortality in vascular surgery patients. Circulation 2002, 106:2366-2371.
5. Landesberg G., Shatz V., Akopnik I., Wof Y., Mayer M., Berlatzky Y., et al. Association of cardiac troponin, CK-MB and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 2003, 42:1547-1554.
6. Filipovic M., Jeger R., Girard T., Probst C., Pfisterer M., Gurke L., et al. Predictors of long-term mortality and cardiac events in patients with known or suspected coronary artery disease who survive major non-cardiac surgery. Anesthesiology 2005, 60:5-11.
7. McFalls E., Ward H., Moritz T., Littooy F., Krupski W., Santilli S., et al. Clinical factors associated with long-term mortality following vascular surgery: outcomes from the Coronary Artery Revascularization Prophylaxis (CARP) trial. J Vasc Surg 2007, 46:694-700.
8. Lee T., Marcantonio E., Mangione C., Thomas E., Polanczyk C., Cook E., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999, 100:1043-1049.
9. Schouten O., Boersma E., Hoeks S., Benner R., van Urk H., van Sambeek M., et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009, 361:980-989.
10. Thygesen K., Alpert J., White H. Universal definition of myocardial infarction. Circulation 2007, 116:2634-2653.
11. Apple F., Wu A., Jaffe A. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002, 144:981-986.
12. Garcia S., Moritz T., Goldman S., Littooy F., Pierpont G., Larsen G., et al. Perioperative complications following vascular surgery are predicted by the Revised Cardiac Risk Index but are not reduced in high risk subsets with preoperative revascularization. Circulation 2009, 2:73-77.
13. Krupski W., Layug E., Reilly L., Rapp J., Mangano D. Comparison of cardiac morbidity between aortic and infrainguinal operations. J Vasc Surg 1992, 15:354-365. The Study of Perioperative Ischemia (SPI) Research Group.
14. Poldermans D., Bax J., Ketai M., Krenning B., Westerhout C., Schinkel A., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003, 107:1848-1851.
15. Hertzer N., Beven E., Young J., O'Hara P., Ruschhaupt W.I., Graor R., et al. Coronary artery disease in peripheral vascular patients: a classification of 1000 coronary angiograms and results of surgical management. Ann. Surg 1984, 199:223-233.
16. Boersma E., Poldermans D., Bax J., Steyerberg E., Thomson I., Banga J., et al. Predictors of cardiac events after major vascular surgery. Role of clinical characteristics, dobutamine ECHO, and beta-blocker therapy. JAMA 2001, 285:1865-1873.
17. Poldermans D., Schouten O., Vidakovic R., Bax J., Thomson I., Hoeks S., et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V pilot study. J Am Coll Cardiol 2007, 49:1763-1769.
18. McFalls E., Ward H., Moritz T., Goldman S., Krupski W., Littooy F., et al. Coronary artery revascularization before elective major vascular surgery. N Engl J Med 2004, 351:2795-2804.
19. Garcia S., Moritz T., Ward H., Pierpont G., Goldman S., Larsen G., et al. Usefulness of revascularization of patients with multivessel coronary artery disease before elective vascular surgery for abdominal aortic and peripheral occlusive disease. Am J Cardiol 2008, 102:809-813.
20. Poldermans D., Boersma E., Bax J., Thomson I., van de Ven L., Blankensteijn J., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999, 341:1789-1794.
21. Mangano D., Layug E., Wallace A., Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996, 335:1713-1720.
22. Devereaux P., Yang H., Yusuf S., Guyatt G., Leslie K., Villar J., et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008, 371:1839-1847. POISE STUDY GROUP.
23. Hoeks S., Scholte O., Reiemer W., van Gestel Y., Schouten O., Lenzen M., et al. Medication underuse during long-term follow-up in patients with peripheral arterial disease. Circ Cardiovasc Qual Outcomes 2009, 2:338-343.